Literature DB >> 6432833

Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.

A L Barry, C Thornsberry, R N Jones, T L Gavan.   

Abstract

In vitro studies with 661 bacterial isolates were performed to establish interpretive criteria. In addition, a nine-laboratory study was performed to establish quality control limits for tests with 100-micrograms apalcillin disks and to confirm testing criteria for tests with 100-micrograms piperacillin disks. The two drugs were very similar, and nearly identical criteria were recommended for interpretation and for control of the two types of disks. Neither disk is recommended for testing Staphylococcus spp. or Haemophilus spp.; with other microorganisms, zone size limits of less than or equal to 13 mm (resistant) and greater than or equal to 18 mm (susceptible) are proposed for tests with 100-micrograms apalcillin disks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432833      PMCID: PMC271184          DOI: 10.1128/jcm.19.6.777-782.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.

Authors:  H Noguchi; M Kubo; S Kurashige; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studies.

Authors:  A L Barry; R N Jones
Journal:  J Antimicrob Chemother       Date:  1982-01       Impact factor: 5.790

4.  Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Authors:  T L Gavan; R N Jones; A L Barry; P C Fuchs; E H Gerlach; J M Matsen; L B Reller; C Thornsberry; L D Thrupp
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

5.  In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

Authors:  A L Barry; C Thornsberry; R N Jones; T L Gavan
Journal:  Cleve Clin Q       Date:  1980

6.  PC-904, a new semisynthetic penicillin.

Authors:  G P Bodey; S Weaver; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

7.  In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation.

Authors:  H Noguchi; Y Eda; H Tobiki; T Nakagome; T Komatsu
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

9.  Piperacillin susceptibility tests by the single-disk agar diffusion technique.

Authors:  A L Barry; C Thornsberry; R E Badal; C N Baker; R N Jones; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

  9 in total
  2 in total

1.  Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.

Authors:  P A Bradford; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.